Successful unrelated donor cord blood transplantation for Glanzmann's thrombasthenia

Pediatric Transplantation

Volumn 15, Issue 3, 2011, Pages

  Kitko, Carrie L ^a   Levine, John E ^a   Matthews, Dana C ^b   Carpenter, Paul A ^b,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

cord blood; Glanzmann's; platelets; thrombasthenia; transplantation

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; AMINOCAPROIC ACID; BUSULFAN; COLLAGEN; CYCLOPHOSPHAMIDE; CYTOMEGALOVIRUS ANTIBODY; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; LEVOTHYROXINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OXYBUTYNIN; PHENAZOPYRIDINE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RISTOCETIN; RITUXIMAB; TACROLIMUS; THROMBOCYTE ANTIBODY; THYMOCYTE ANTIBODY; VALGANCICLOVIR;

ANTIBODY PRODUCTION; ANTIVIRAL THERAPY; ARTICLE; BLEEDING; CAPILLARY LEAK SYNDROME; CASE REPORT; CENTRAL VENOUS CATHETERIZATION; CHILD; CHIMERA; CIRCUMCISION; CONTINUOUS INFUSION; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DYSURIA; EPISTAXIS; ERYTHROCYTE TRANSFUSION; FLOW CYTOMETRY; GASTROINTESTINAL HEMORRHAGE; GLANZMANN DISEASE; GRAFT VERSUS HOST REACTION; HEMARTHROSIS; HEMATOTHORAX; HEMATURIA; HEMORRHAGIC SHOCK; HEMOSTASIS; HUMAN; HYPOTHYROIDISM; HYPOVOLEMIC SHOCK; IMMUNOSUPPRESSIVE TREATMENT; MALE; ORAL BLEEDING; ORGAN DONOR; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; PETECHIA; PLEURA EFFUSION; PRESCHOOL CHILD; PROTEIN EXPRESSION; SCHOOL CHILD; SKIN BRUISING; SURGICAL DRAINAGE; THORACOTOMY; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; VIRURIA; VIRUS REACTIVATION;

BLOOD PLATELET DISORDERS; BLOOD PLATELETS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS; CHILD; CHILD, PRESCHOOL; FETAL BLOOD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGE; HUMANS; MALE; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; THROMBASTHENIA; TREATMENT OUTCOME;

EID: 79954476780     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2009.01251.x     Document Type: Article

References (15)

1. Bellucci S, Devergie A, Gluckman E, et al., Complete correction of Glanzmann's thrombasthenia by allogeneic bone-marrow transplantation. Br J Haematol 1985: 59: 635-641. (Pubitemid 15133655)
2. Johnson A, Goodall AH, Downie CJ, Vellodi A, Michael DP,. Bone marrow transplantation for Glanzmann's thrombasthenia. Bone Marrow Transplant 1994: 14: 147-150. (Pubitemid 24228752)
3. Mccoll MD, Gibson BES,. Sibling allogeneic bone marrow transplantation in a patient with type I Glanzmann's thrombasthenia. Br J Haematol 1997: 99: 58-60. (Pubitemid 27461328)
4. Belluci S, Damaj G, Boval B, et al., Bone marrow transplantation in Glanzmann's thromasthenia with antiplatelet alloimmunization. Bone Marrow Transplant 2000: 25: 327-330. (Pubitemid 30103025)
5. Fujimoto T-T, Kishimoto M, Ide K, et al., Glanzmann thrombasthenia with acute myeloid leukemia successfully treated by bone marrow transplantation. Int J Hematol 2005: 81: 77-80. (Pubitemid 40165430)
6. Flood VH, Johnson FL, Boshkov LK, et al., Sustained engraftment post bone marrow transplant despite anti-platelet antibodies in Glanzmann thrombasthenia. Pediatr Blood Cancer 2005: 45: 971-975. (Pubitemid 41552168)
7. Connor P, Khair K, Liesner R, et al., Stem cell transplantation for children with Glanzmann thrombasthenia. Br J Haematol 2008: 140: 568-571. (Pubitemid 351230067)
8. Ishaqi MK, El-Hayek M, Gassas A, et al., Allogeneic stem cell transplantation for Glanzmann thrombasthenia. Pediatr Blood Cancer 2009: 52: 682-683.
9. Poon MC, D'oiron R, Hann I, et al., Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia. Semin Hematol 2001: 38: 21-25. (Pubitemid 33130035)
10. Parodi E, Rivetti E, Amendola G, et al., Long-term follow-up analysis after rituximab therapy in children with refractory symptomatic ITP: Identification of factors predictive of a sustained response. Br J Haematol 2009: 144: 552-558.
11. Cutler C, Miklos D, Kim HT, et al., Rituximab for steroid-refractory chronic graft-versus-host disease. Blood 2006: 108: 756-762. (Pubitemid 44061381)
12. Page KM, Mendizabal AM, Prasad VK, et al., Posttransplant autoimmune hemolytic anemia and other autoimmune cytopenias are increased in very young infants undergoing unrelated donor umbilical cord blood transplantation. Biol Blood Marrow Transplant 2008: 14: 1108-1117.
13. Vo AA, Lukovsky M, Toyoda M, et al., Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med 2008: 359: 242-251. (Pubitemid 352008439)
14. Vieira CA, Agarwal A, Book BK, et al., Rituximab for reduction of anti-HLA antiboidies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics. Transplantation 2004: 77: 542-548. (Pubitemid 38282809)
15. Sonnenday CJ, Warren DS, Cooper M, et al., Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. Am J Transplant 2004: 4: 1315-1322. (Pubitemid 39013579)